|
RB1CC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.565000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.16100000000052E-05 |
| Normal-vs-Stage2 |
1.961770E-01 |
| Normal-vs-Stage3 |
7.989600E-01 |
| Normal-vs-Stage4 |
9.874200E-01 |
| Stage1-vs-Stage2 |
2.324600E-01 |
| Stage1-vs-Stage3 |
9.615100E-03 |
| Stage1-vs-Stage4 |
5.662300E-02 |
| Stage2-vs-Stage3 |
4.099600E-01 |
| Stage2-vs-Stage4 |
4.315400E-01 |
| Stage3-vs-Stage4 |
8.939400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.391500E-04 |
| Normal-vs-AfricanAmerican |
4.664300E-03 |
| Normal-vs-Asian |
5.569000E-01 |
| Caucasian-vs-AfricanAmerican |
8.372000E-01 |
| Caucasian-vs-Asian |
7.072600E-01 |
| AfricanAmerican-vs-Asian |
6.689200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.94350000002086E-06 |
| Normal-vs-Female |
9.381000E-01 |
| Male-vs-Female |
2.09860000000006E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.040200E-02 |
| Normal-vs-Extreme_Weight |
1.69070000000104E-06 |
| Normal-vs-Obese |
9.917900E-02 |
| Normal-vs-Extreme_Obese |
2.475800E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.371010E-01 |
| Normal_Weight-vs-Obese |
5.256200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.994400E-01 |
| Extreme_Weight-vs-Obese |
7.963100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.056200E-01 |
| Obese-vs-Extreme_Obese |
4.152400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.433000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.672100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.57429999997549E-06 |
| Normal-vs-Age(81-100Yrs) |
3.431200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.439800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.593260E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.800100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.697400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.747800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.373400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.66272999999606E-05 |
| Normal-VS-Type2 PRCC |
9.164300E-03 |
| Normal-VS-KIRP CIMP |
1.459850E-02 |
| Normal-VS-Unclassified PRCC |
2.480200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.737600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.12869999966148E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
6.040000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.828200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.175400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.162000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.788400E-04 |
| Normal-vs-N1 |
1.784050E-01 |
| Normal-vs-N2 |
6.364400E-01 |
| N0-vs-N1 |
3.567400E-04 |
| N0-vs-N2 |
3.667800E-01 |
| N1-vs-N2 |
4.218400E-01 |
|
|
